Page last updated: 2024-10-25

deferoxamine and Hyperbilirubinemia, Hereditary

deferoxamine has been researched along with Hyperbilirubinemia, Hereditary in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Hyperbilirubinemia, Hereditary: Inborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reddemann, H1

Other Studies

1 other study available for deferoxamine and Hyperbilirubinemia, Hereditary

ArticleYear
[Exchange transfusion and splenectomy for hyperbilirubinemia caused by hereditary spherocytosis in the neonatal period].
    Zeitschrift fur Kinderheilkunde, 1967, Volume: 100, Issue:3

    Topics: Deferoxamine; Exchange Transfusion, Whole Blood; Female; Hemosiderosis; Humans; Hyperbilirubinemia,

1967